[1]
H. S. Santoki, D. M. Shukla, S. V. Sood, and S. D. Malhotra, “Tocilizumab induced immunosuppression in a case of adult-onset still’s disease: are these newer biologics double edged sword?”, Int J Basic Clin Pharmacol, vol. 11, no. 5, pp. 487–489, Aug. 2022.